In the previous 12 months, the patients had an average of 5.6 episodes of herpes labialis. The median age of these patients was 44 years (range 18 to 80 years), 72% were women, and 91% were white.

While 48% of participants reported feeling upset by images of psoriasis, mostly due to color, scale, thickness and size of lesions (95% CI, 35.1-61.3), a significantly higher number of survey ...

The Herpes Labialis Treatment Market is growing steadily as awareness about cold sore management increases. Herpes labialis, commonly known as cold sores, is caused by the herpes simplex virus (HSV-1) ...

Second BioAlliance Pharma drug registered in the US An effective and innovative medicine for the treatment of a frequent infection, recurrent Herpes labialis in adults Paris, April 15, 2013 ...

McCune et al. [14] enrolled 47 immunocompetent patients with recurrent herpes labialis outbreaks in a study to determine the efficacy of oral lysine for prophylaxis.

Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial. eClinicalMedicine, 64, 102203. doi: 10.1016/j.eclinm.2023.102203 ...

ANN ARBOR, Mich., March 17 /PRNewswire/ -- NanoBio Corporation reported top-level findings today from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores). The ...

Topical Lipophilic Epigallocatechin-3-Gallate on Herpes Labialis: A Phase II Clinical Trial of AverTeaX Formula Zhao M, Zheng R, Jiang J, et al Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120 ...

Results from the Phase 2 study demonstrated that a single topical dose of SQX770 applied to the upper arm significantly extended time to next herpes labialis outbreak and reduced both the ...

Home News Stock News Herpes Labialis (Oral Herpes) Disease - Global Clinical Trials Review, H2 2020 ...